S&P 500   4,632.24 (-0.49%)
DOW   34,921.34 (-0.61%)
QQQ   400.46 (+0.19%)
AAPL   164.47 (+2.64%)
MSFT   337.52 (+0.26%)
FB   334.84 (-0.94%)
GOOGL   2,903.65 (-0.24%)
AMZN   3,568.73 (+0.20%)
TSLA   1,163.00 (+2.29%)
NVDA   331.96 (-0.54%)
BABA   129.54 (-1.57%)
NIO   40.71 (+0.62%)
CGC   10.82 (-2.17%)
AMD   163.30 (+0.86%)
GE   96.21 (-2.23%)
MU   86.16 (+0.02%)
T   23.04 (-3.56%)
F   19.56 (-0.56%)
DIS   145.79 (-1.37%)
ACB   6.42 (-0.31%)
AMC   35.46 (-3.75%)
PFE   53.73 (+2.54%)
BA   197.21 (-0.65%)
S&P 500   4,632.24 (-0.49%)
DOW   34,921.34 (-0.61%)
QQQ   400.46 (+0.19%)
AAPL   164.47 (+2.64%)
MSFT   337.52 (+0.26%)
FB   334.84 (-0.94%)
GOOGL   2,903.65 (-0.24%)
AMZN   3,568.73 (+0.20%)
TSLA   1,163.00 (+2.29%)
NVDA   331.96 (-0.54%)
BABA   129.54 (-1.57%)
NIO   40.71 (+0.62%)
CGC   10.82 (-2.17%)
AMD   163.30 (+0.86%)
GE   96.21 (-2.23%)
MU   86.16 (+0.02%)
T   23.04 (-3.56%)
F   19.56 (-0.56%)
DIS   145.79 (-1.37%)
ACB   6.42 (-0.31%)
AMC   35.46 (-3.75%)
PFE   53.73 (+2.54%)
BA   197.21 (-0.65%)
S&P 500   4,632.24 (-0.49%)
DOW   34,921.34 (-0.61%)
QQQ   400.46 (+0.19%)
AAPL   164.47 (+2.64%)
MSFT   337.52 (+0.26%)
FB   334.84 (-0.94%)
GOOGL   2,903.65 (-0.24%)
AMZN   3,568.73 (+0.20%)
TSLA   1,163.00 (+2.29%)
NVDA   331.96 (-0.54%)
BABA   129.54 (-1.57%)
NIO   40.71 (+0.62%)
CGC   10.82 (-2.17%)
AMD   163.30 (+0.86%)
GE   96.21 (-2.23%)
MU   86.16 (+0.02%)
T   23.04 (-3.56%)
F   19.56 (-0.56%)
DIS   145.79 (-1.37%)
ACB   6.42 (-0.31%)
AMC   35.46 (-3.75%)
PFE   53.73 (+2.54%)
BA   197.21 (-0.65%)
S&P 500   4,632.24 (-0.49%)
DOW   34,921.34 (-0.61%)
QQQ   400.46 (+0.19%)
AAPL   164.47 (+2.64%)
MSFT   337.52 (+0.26%)
FB   334.84 (-0.94%)
GOOGL   2,903.65 (-0.24%)
AMZN   3,568.73 (+0.20%)
TSLA   1,163.00 (+2.29%)
NVDA   331.96 (-0.54%)
BABA   129.54 (-1.57%)
NIO   40.71 (+0.62%)
CGC   10.82 (-2.17%)
AMD   163.30 (+0.86%)
GE   96.21 (-2.23%)
MU   86.16 (+0.02%)
T   23.04 (-3.56%)
F   19.56 (-0.56%)
DIS   145.79 (-1.37%)
ACB   6.42 (-0.31%)
AMC   35.46 (-3.75%)
PFE   53.73 (+2.54%)
BA   197.21 (-0.65%)
NASDAQ:EXAI

Exscientia Stock Forecast, Price & News

$21.23
-0.66 (-3.02%)
(As of 11/30/2021 10:09 AM ET)
Add
Compare
Today's Range
$21.23
$21.44
50-Day Range
N/A
52-Week Range
$19.03
$30.38
Volume
108 shs
Average Volume
59,712 shs
Market Capitalization
$2.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive EXAI News and Ratings via Email

Sign-up to receive the latest news and ratings for Exscientia and its competitors with MarketBeat's FREE daily newsletter.


About Exscientia

Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.

Headlines

Exscientia Business Update for Third Quarter 2021
November 17, 2021 |  finance.yahoo.com
Exscientia (EXAI) to Release Quarterly Earnings on Wednesday
November 12, 2021 |  americanbankingnews.com
Exscientia Plc American Depositary Shares (EXAI)
October 15, 2021 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EXAI
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$2.50 billion
Optionable
Not Optionable

Company Calendar

Today
11/30/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/16/2022

MarketRank

Overall MarketRank

1.35 out of 5 stars

Medical Sector

1130th out of 1,390 stocks

Analyst Opinion: 2.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Exscientia (NASDAQ:EXAI) Frequently Asked Questions

Is Exscientia a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exscientia in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Exscientia stock.
View analyst ratings for Exscientia
or view top-rated stocks.

When is Exscientia's next earnings date?

Exscientia is scheduled to release its next quarterly earnings announcement on Wednesday, February 16th 2022.
View our earnings forecast for Exscientia
.

What price target have analysts set for EXAI?

3 Wall Street analysts have issued 12 month price targets for Exscientia's stock. Their forecasts range from $25.00 to $30.00. On average, they expect Exscientia's stock price to reach $27.33 in the next year. This suggests a possible upside of 28.7% from the stock's current price.
View analysts' price targets for Exscientia
or view top-rated stocks among Wall Street analysts.

When did Exscientia IPO?

(EXAI) raised $291 million in an initial public offering (IPO) on Friday, October 1st 2021. The company issued 13,850,000 shares at $20.00-$22.00 per share.

What is Exscientia's stock symbol?

Exscientia trades on the NASDAQ under the ticker symbol "EXAI."

When did the company's quiet period expire?

Exscientia's quiet period expired on Wednesday, November 10th. Exscientia had issued 13,850,000 shares in its public offering on October 1st. The total size of the offering was $304,700,000 based on an initial share price of $22.00. During the company's quiet period, insiders and any underwriters that worked on the IPO were restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Exscientia?

Shares of EXAI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exscientia's stock price today?

One share of EXAI stock can currently be purchased for approximately $21.23.

How much money does Exscientia make?

Exscientia has a market capitalization of $2.50 billion.


This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.